Advances in Immunology
Series:
Advances in Immunology;
147;
Publisher: Academic Press
Date of Publication: 1 October 2020
Normal price:
Publisher's listprice:
EUR 145.00
EUR 145.00
Your price:
53 851 (51 287 HUF + 5% VAT )
discount is: 10% (approx 5 983 HUF off)
The discount is only available for 'Alert of Favourite Topics' newsletter recipients.
Click here to subscribe.
Click here to subscribe.
Availability:
printed on demand
Can't you provide more accurate information?
Product details:
| ISBN13: | 9780128207567 |
| ISBN10: | 0128207566 |
| Binding: | Hardback |
| No. of pages: | 146 pages |
| Size: | 229x151 mm |
| Weight: | 340 g |
| Language: | English |
| 250 |
Category:
Long description:
Advances in Immunology, Volume 147, the latest release in a long-established and highly respected publication, presents current developments and comprehensive reviews in immunology. Chapters in this new release include Histone deacetylases as targets in autoimmune and autoinflammatory diseases, The advancing area of the mechanisms involved in the evolution of HIV-1 neutralizing antibodies, T cells in latent viral infections, Communications of dendritic cells with T cells and NK cells in cancerous tissues, Mechanism and Regulation of Class Switch Recombination by IgH transcriptional Control Elements, IL-2 partial agonist, Preserving Immune Homeostasis with A20, The design of vaccine strategies to elicit HIV-1 broadly neutralizing antibodies.
Table of Contents:
1. Histone deacetylases as targets in autoimmune and autoinflammatory diseases Wilfried Ellmeier 2. The advancing area of the mechanisms involved in the evolution of HIV
-1 neutralizing antibodies Mattia Bonsignori 3. T cells in latent viral infections Dietmar Zehn 4. Communications of dendritic cells with T cells and NK cells in cancerous tissues Jan Böttcher 5. Mechanism and Regulation of Class Switch Recombination by IgH transcriptional Control Elements Amine Khamlichi 6. IL
-2 partial agonist Warren Leonard 7. Preserving Immune Homeostasis with A20 Averil Ma 8. The design of vaccine strategies to elicit HIV
-1 broadly neutralizing antibodies Joseph Jardine
